Victor Dzau is President of the National Academy of Medicine, Vice-Chair of the National Research Council, Chancellor Emeritus of Duke University, and past CEO of Duke Health System. Previously, he was Professor and Chairman of Medicine at both Harvard and Stanford Universities. Dr. Dzau is recognized globally for a long and highly decorated career as a scientist, administrator, and leader. His research laid the foundation for development of lifesaving drugs known as ACE inhibitors, used globally to treat high blood pressure and congestive heart failure.
Under Dzau’s tenure, the NAM has undertaken important initiatives with US and global impact. These include the Global Health Risk Framework, the Human Genome Editing Initiative, the Global Roadmap for Healthy Longevity, and the G20 report on Financing the Global Commons for Pandemic Preparedness and Response. Currently, he co-chairs World Economic Forum’s Regional Vaccine Manufacturing Collaborative. In 2020, the NAM launched the Grand Challenge in Climate Change and Health aimed at reversing the effects of climate on health through interventions, research, communication, and policy; and decarbonizing the health care sector.